Aberrant N-cadherin expression in cancer.
Aberrant N-cadherin expression in cancer.
Biomed Pharmacother. 2019 Oct;118:109320
Authors: Cao ZQ, Wang Z, Leng P
Abstract
Neural (N)-cadherin is a calcium-dependent single-chain transmembrane glycoprotein that mediates homotypic and heterotypic cell-cell adhesion. As an important member of the cadherin family, N-cadherin plays an important role in the developmental and functional regulation of the nervous system, brain, heart, skeletal muscles, blood vessels and hematopoietic microenvironment. However, aberrant expression of N-cadherin has been found in many cancers, such as lung cancer, breast cancer, prostate cancer and squamous cell carcinoma. It is increasingly recognized that aberrant expression of N-cadherin is closely related to aspects of malignant tumor progression in humans, such as transformation, adhesion, apoptosis, angiogenesis, invasion and metastasis, suggesting that N-cadherin can be a therapeutic target for tumor invasion and metastasis. This minireview summarizes the diverse roles of N-cadherin in cancer progression and the regulatory factors that affect the expression of N-cadherin in cancer, findings that increase our awareness of the importance of developing new therapeutic agents targeting N-cadherin.
PMID: 31545265 [PubMed - in process]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Cao ZQ, Wang Z, Leng P Tags: Biomed Pharmacother Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Breast Carcinoma | Calcium | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Drugs & Pharmacology | Heart | Lung Cancer | Neurology | Prostate Cancer | Science | Skin Cancer | Squamous Cell Carcinoma